Tech Company Financing Transactions
Elevian Funding Round
On 9/20/2021, Elevian landed $40 million in Series A funding from Prime Movers Lab, Bold Capital Partners and Kuelbs Family Office.
Transaction Overview
Company Name
Announced On
9/20/2021
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series A
Investors
Prime Movers Lab (Lead Investor) (Suzanne Fletcher)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
127 Western Ave.
Allston, MA 02134
USA
Allston, MA 02134
USA
Phone
Undisclosed
Website
Email Address
Overview
At Elevian, we develop new medicines to restore regenerative capacity, with the potential to prevent and treat many age-related diseases. Our mission is to help people age, unburdened by the diseases of aging.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Allen
Chief Financial Officer
Gregory Curhan
VP - R & D
Tony Sandrasagra
Browse more venture capital transactions:
Prev: 9/20/2021: Aira Technologies venture capital transaction
Next: 9/20/2021: Whatnot venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions on this site are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs